Back to Agenda
SESSION 3: TECHNICAL ISSUES
Session Chair(s)
Judith Creba, PhD
Sr. Global Program Regulatory Director, Reg Affairs GDD Region EU
Novartis Pharma AG, Switzerland
Speaker(s)
Annex VI: Discussion of the Key Issues and How to Address Them: Sini Eskola, MPharm, MS, MSc
Director Regulatory Affairs
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
Implementation Guidance and Delegated Acts - Awareness of and the Key Identified Issues from the Draft Guidance: Isabelle Clamou
Policy Officer, DG SANTE Unit D2
European Commission, Belgium
Maja Leon-Grzymkowska
Legal Officer at European Commission
European Commission, Belgium
Have an account?